Cargando…
Lysophosphatidylinositol Causes Neurite Retraction via GPR55, G(13) and RhoA in PC12 Cells
GPR55 was recently identified as a putative receptor for certain cannabinoids, and lysophosphatidylinositol (LPI). Recently, the role of cannabinoids as GPR55 agonists has been disputed by a number of reports, in part, because studies investigating GPR55 often utilized overexpression systems, such a...
Autores principales: | Obara, Yutaro, Ueno, Sanae, Yanagihata, Yoshimi, Nakahata, Norimichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3164175/ https://www.ncbi.nlm.nih.gov/pubmed/21904624 http://dx.doi.org/10.1371/journal.pone.0024284 |
Ejemplares similares
-
Lysophosphatidylinositol Induced Morphological Changes and Stress Fiber Formation through the GPR55-RhoA-ROCK Pathway
por: Nakajima, Keisuke, et al.
Publicado: (2022) -
Peptide targeting of lysophosphatidylinositol-sensing GPR55 for osteoclastogenesis tuning
por: Mosca, Maria Giovanna, et al.
Publicado: (2021) -
GPR55-dependent and -independent ion signalling in response to lysophosphatidylinositol in endothelial cells
por: Bondarenko, Alexander, et al.
Publicado: (2010) -
The l-α-Lysophosphatidylinositol/GPR55 System and Its Potential Role in Human Obesity
por: Moreno-Navarrete, José María, et al.
Publicado: (2012) -
The GPR 55 agonist, L-α-lysophosphatidylinositol, mediates ovarian carcinoma cell-induced angiogenesis
por: Hofmann, Nicole A, et al.
Publicado: (2015)